BCMA-Targeted CAR T-cell Therapy plus Radiotherapy for the Treatment of Refractory Myeloma Reveals Potential Synergy

Overview of attention for article published in Cancer Immunology Research, July 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter: 34 X users

patent: 4 patents

Readers on

mendeley: 100 Mendeley

So far, Altmetric has seen 38 X posts from 34 X users, with an upper bound of 138,935 followers.

RT @RahulBanerjeeMD: Thoughtful review of XRT and CAR-T in @JAMAOnc - as relevant to lymphoma as to solid tumors. Includes case report I h…

Thoughtful review of XRT and CAR-T in @JAMAOnc - as relevant to lymphoma as to solid tumors. Includes case report I hadn’t seen - delayed CRS and ?? abscopal effect with XRT 5 days after BCMA CAR-T. Of course, n=1 and specific circumstances (spine mass).…

BCMA-targeted CAR T-cell therapy plus radiation therapy for the treatment of refractory myeloma reveals potential synergy https://t.co/OgFce3p6wi

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 34 additional X posts.